Update: FDA clears first generic of AZ’s blockbuster Symbicort
pharmaphorum
MARCH 16, 2022
Viatris’ generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been cleared for the same indications as the brand, namely maintenance treatment for asthma and chronic obstructive pulmonary disease (COPD).
Let's personalize your content